“…DWI can be used to distinguish benign from malignant lesions in the lung Ohba et al, 2009;, in the thorax (Tondo et al, 2011), in the prostate (Yamamura et al, 2011), in the breast (Fornasa et al, 2011), and in the liver (Koike et al, 2009;. DWI was reported to be superior to FDG-PET in the detection of primary lesions and the nodal assessment of non-small cell lung cancers (Usuda et al, 2011;Wu et al, 2012). The advantages of DWI can be explained not only by DWI giving fewer false-positive results for N staging of non-small cell lung cancer compared with FDG-PET , but also by DWI giving fewer false-negative results (Usuda et al, 2011).…”